|
"platt r"的相關文件
顯示項目 16-25 / 39 (共4頁)
<< < 1 2 3 4 > >>
每頁顯示[10|25|50]項目
| 臺大學術典藏 |
2018-09-10T06:14:03Z |
Laboratory evaluation of potassium and creatinine among ambulatory patients prescribed spironolactone: Are we monitoring for hyperkalemia?
|
Raebel, M.A.;Mcclure, D.L.;Chan, K.A.;Simon, S.R.;Feldstein, A.C.;Lafata, J.E.;Andrade, S.E.;Gunter, M.J.;Nelson, W.W.;Roblin, D.;Platt, R.; Kin-Wei Chan |
| 臺大學術典藏 |
2018-09-10T06:14:03Z |
Laboratory monitoring of potassium and creatinine in ambulatory patients receiving angiotensin converting enzyme inhibitors and angiotensin receptor blockers
|
Raebel, M.A.;Mcclure, D.L.;Simon, S.R.;Chan, K.A.;Feldstein, A.;Andrade, S.E.;Lafata, J.E.;Roblin, D.;Davis, R.L.;Gunter, M.J.;Platt, R.; Kin-Wei Chan |
| 臺大學術典藏 |
2018-09-10T06:14:02Z |
Asthma drug use and the development of Churg-Strauss syndrome (CSS)
|
Harrold, L.R.;Patterson, M.K.;Andrade, S.E.;Dube, T.;Go, A.S.;Buist, A.S.;Chan, K.A.;Weller, P.F.;Wechsler, M.E.;Yood, R.A.;Davis, K.J.;Platt, R.;Walker, A.M.; Kin-Wei Chan |
| 臺大學術典藏 |
2018-09-10T05:45:53Z |
Monitoring of drugs with a narrow therapeutic range in ambulatory care
|
Raebel, M.A.;Carroll, N.M.;Andrade, S.E.;Chester, E.A.;Lafata, J.E.;Feldstein, A.;Gunter, M.J.;Nelson, W.W.;Simon, S.R.;Chan, K.A.;Davis, R.L.;Platt, R.; Kin-Wei Chan |
| 臺大學術典藏 |
2018-09-10T05:45:53Z |
Potential drugg-drug interactions in the outpatient setting
|
Lafata, J.E.;Schultz, L.;Simpkins, J.;Chan, K.A.;Horn, J.R.;Kaatz, S.;Long, C.;Platt, R.;Raebel, M.A.;Smith, D.H.;Xi, H.;Yood, M.U.; Kin-Wei Chan |
| 臺大學術典藏 |
2018-09-10T05:45:52Z |
Frequency of high-risk use of QT-prolonging medications
|
Allen Lapointe, N.M.;Curtis, L.H.;Chan, K.A.;Kramer, J.M.;Lafata, J.E.;Gurwitz, J.H.;Raebel, M.A.;Platt, R.; Kin-Wei Chan |
| 臺大學術典藏 |
2018-09-10T05:11:42Z |
Incidence of Churg-Strauss syndrome in asthma drug users: A population-based perspective
|
Harrold, L.R.;Andrade, S.E.;Go, A.S.;Buist, A.S.;Eisner, M.;Vollmer, W.M.;Chan, K.A.;Frazier, E.A.;Weller, P.F.;Wechsler, M.E.;Yood, R.A.;Davis, K.J.;Platt, R.; Kin-Wei Chan |
| 臺大學術典藏 |
2018-09-10T05:11:42Z |
Laboratory monitoring of drugs at initiation of therapy in ambulatory care
|
Raebel, M.A.;Lyons, E.E.;Andrade, S.E.;Chan, K.A.;Chester, E.A.;Davis, R.L.;Ellis, J.L.;Feldstein, A.;Gunter, M.J.;Lafata, J.E.;Long, C.L.;Magid, D.J.;Selby, J.V.;Simon, S.R.;Platt, R.; Kin-Wei Chan |
| 臺大學術典藏 |
2018-09-10T05:11:42Z |
Rhabdomyolysis and lipid-lowering drugs [2] (multiple letters)
|
Tenenbaum, A.;Fisman, E.Z.;Motro, M.;Graham, D.J.;Staffa, J.A.;La Grenade, L.;Shatin, D.;Schech, S.D.;Andrade, S.E.;Gurwitz, J.H.;Goodman, M.J.;Chan, K.A.;Platt, R.; Kin-Wei Chan |
| 臺大學術典藏 |
2018-09-10T05:11:41Z |
Health plan administrative databases can efficiently identify serious myopathy and rhabdomyolysis
|
Andrade, S.E.;Graham, D.J.;Staffa, J.A.;Schech, S.D.;Shatin, D.;La Grenade, L.;Goodman, M.J.;Platt, R.;Gurwitz, J.H.;Chan, K.A.; Kin-Wei Chan |
顯示項目 16-25 / 39 (共4頁)
<< < 1 2 3 4 > >>
每頁顯示[10|25|50]項目
|
